TGFB1 and benign prostatic hyperplasia: Although various cellular pathways have been reported to be involved in BPH, such as nuclear factor-kappa B (NF-kappaB) signaling pathway, TGF-β1 signaling pathway, and inflammation related pathways, EMT is commonly considered at the downstream of these pathways in BPH [44–46].